These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 6487486)

  • 1. Atenolol pharmacokinetics in patients on continuous ambulatory peritoneal dialysis.
    Salahudeen AK; Wilkinson R; McAinsh J; Bateman DN
    Br J Clin Pharmacol; 1984 Sep; 18(3):457-60. PubMed ID: 6487486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic and pharmacodynamic modelling of atenolol in rabbits maintained on continuous peritoneal dialysis.
    Celardo A; Traina GL; Arboix M; Puigdemont A; Bonati M
    Eur J Drug Metab Pharmacokinet; 1987; 12(1):41-8. PubMed ID: 3609072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of ornidazole in patients with renal insufficiency; influence of haemodialysis and peritoneal dialysis.
    Merdjan H; Baumelou A; Diquet B; Chick O; Singlas E
    Br J Clin Pharmacol; 1985 Feb; 19(2):211-7. PubMed ID: 3986079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quinidine pharmacokinetics in continuous ambulatory peritoneal dialysis.
    Chin TW; Pancorbo S; Comty C
    Clin Exp Dial Apheresis; 1981; 5(4):391-7. PubMed ID: 7341025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of teicoplanin in patients on continuous ambulatory peritoneal dialysis.
    Traina GL; Gentile MG; Fellin G; Rosina R; Cavenaghi L; Buniva G; Bonati M
    Eur J Clin Pharmacol; 1986; 31(4):501-4. PubMed ID: 2949981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of atenolol in patients with terminal renal failure and influence of haemodialysis.
    Flouvat B; Decourt S; Aubert P; Potaux L; Domart M; Goupil A; Baglin A
    Br J Clin Pharmacol; 1980 Apr; 9(4):379-85. PubMed ID: 7378254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acyclovir pharmacokinetics in a patient on continuous ambulatory peritoneal dialysis.
    Shah GM; Winer RL; Krasny HC
    Am J Kidney Dis; 1986 Jun; 7(6):507-10. PubMed ID: 3717158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The effect of recombinant human growth hormone on urea and creatinine kinetics and selected dialysis adequacy parameters in children with end-stage renal failure treated with peritoneal dialysis].
    Jedrzejowski A; Dyras P; Pańczyk-Tomaszewska M; Mizerska-Wasiak M; Roszkowska-Blaim M; Pietrzyk JA; Gałazka B
    Pol Merkur Lekarski; 2002 Sep; 13(75):191-5. PubMed ID: 12474568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of intraperitoneal teicoplanin in patients with chronic renal failure on continuous ambulatory peritoneal dialysis.
    Bonati M; Traina GL; Gentile MG; Fellin G; Rosina R; Cavenaghi L; Buniva G
    Br J Clin Pharmacol; 1988 Jun; 25(6):761-5. PubMed ID: 2974299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of intravenous and intraperitoneal cefotaxime in chronic ambulatory peritoneal dialysis.
    Albin HC; Demotes-Mainard FM; Bouchet JL; Vincon GA; Martin-Dupont C
    Clin Pharmacol Ther; 1985 Sep; 38(3):285-9. PubMed ID: 4028623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phosphate clearance in peritoneal dialysis: automated PD compared with continuous ambulatory PD.
    Sawin DA; Himmele R; Diaz-Buxo JA
    Adv Perit Dial; 2012; 28():120-5. PubMed ID: 23311227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beta 2-microglobulin elimination in end-stage renal disease patients on renal replacement therapy.
    Stefanović V; Kostić S; Djordjević V; Mitić M; Bogicević M
    Perit Dial Int; 1993; 13 Suppl 2():S520-2. PubMed ID: 8399654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of ceftizoxime in patients undergoing continuous ambulatory peritoneal dialysis.
    Burgess ED; Blair AD
    Antimicrob Agents Chemother; 1983 Aug; 24(2):237-9. PubMed ID: 6314887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urea kinetic modelling in two groups of patients on continuous ambulatory peritoneal dialysis.
    Barton EN; Morgan AG; Burden RP
    West Indian Med J; 1997 Jun; 46(2):57-9. PubMed ID: 9260536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alleviation of sleep apnea in patients with chronic renal failure by nocturnal cycler-assisted peritoneal dialysis compared with conventional continuous ambulatory peritoneal dialysis.
    Tang SC; Lam B; Ku PP; Leung WS; Chu CM; Ho YW; Ip MS; Lai KN
    J Am Soc Nephrol; 2006 Sep; 17(9):2607-16. PubMed ID: 16885414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biochemical parameters, nutritional status and efficiency of dialysis in CAPD and CCPD patients.
    Gao H; Lew SQ; Bosch JP
    Am J Nephrol; 1999; 19(1):7-12. PubMed ID: 10085443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Designing dialysis prescriptions.
    Manuel A; Gray B; Coulis N; Brunier G; Desson F; Paton MA; Tobe S
    Adv Perit Dial; 1996; 12():136-42. PubMed ID: 8865888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peritoneal dialysis adequacy and risk of death.
    Rocco M; Soucie JM; Pastan S; McClellan WM
    Kidney Int; 2000 Jul; 58(1):446-57. PubMed ID: 10886593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exfoliated mesothelial cell and CA-125 in automated peritoneal dialysis (APD) and continuous ambulatory peritoneal dialysis (CAPD) patients.
    Kanjanabuch T; Puttipittayathorn N; Leelahavanichkul A; Lieusuwan S; Katavetin P; Mahatanan N; Sriudom K; Chirananthavat T; Thongbor N; Eiam-Ong S
    J Med Assoc Thai; 2011 Sep; 94 Suppl 4():S119-25. PubMed ID: 22043578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peritoneal transport status influence on atherosclerosis/inflammation in CAPD patients.
    Sezer S; Tutal E; Arat Z; Akçay A; Celik H; Ozdemir FN; Haberal M
    J Ren Nutr; 2005 Oct; 15(4):427-34. PubMed ID: 16198934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.